Fig 1: Lgi1D51G protein is unstable and secretion‐defective in mouse brain. (A) Western blot of cortex lysates from wild‐type, Lgi1D51G /+ and Lgi1D51G /D51G mice at P22 with anti‐Lgi1 antibody. Gapdh was used as reference. (B) Quantification of Lgi1 protein expression in mouse cortices from two experiments. Lgi1 expression levels relative to Gapdh were normalized to that in wild‐type mice. wild‐type, 100.0 ± 2.4%, n = 8; Lgi1D51G /+, 49.3 ± 4.7%, n = 10; Lgi1D51G /D51G , 16.6 ± 3.0%, n = 8. Data are shown as mean ± SEM. *p < 0.05; ****p < 0.0001 Nonparametric Kruskal–Wallis one‐way ANOVA followed by Dunn's multiple comparisons test. (C) Relative mRNA expression levels of Lgi1 in cortices of wild‐type (100.0 ± 9.5% n = 6), Lgi1D51G /+ (100.7 ± 14.3%, n = 9) and Lgi1D51G /D51G (97.8 ± 16.9%, n = 5). Gapdh was used as the reference. Data are shown as mean ± SEM. ns, not significant. One‐way ANOVA followed by Tukey's multiple comparisons test. (D) Immunohistochemical analysis of Lgi1 in hippocampus of wild‐type, Lgi1D51G /+ and Lgi1D51G /D51G mice at P24. Scale bar, 100μm. (E) Immunofluorescence staining of Lgi1 in the cortices of wild‐type, Lgi1D51G /+ and Lgi1D51G /D51G mice at P24. Scale bar, 20μm. (F‐H) The expression (G) and secretion (H) of Lgi1 protein in cortical neurons extracted from wild‐type (secretion, 100.0 ± 8.8%, n = 5), Lgi1D51G /+(secretion, 45.7 ± 13.9%, n = 5) and Lgi1D51G /D51G (secretion, 32.1 ± 5.6%, n = 4) mice. Data are shown as mean ±SEM. **p < 0.01; ns, not significant. One‐way ANOVA followed by Tukey's multiple comparisons test
Fig 2: Spontaneous seizures in homozygous LGI1−/− mice. Frames from a video recording of a spontaneous seizure in a postnatal day 16 LGI1−/− mouse. (A) Onset of the seizure with forelimb and hind limb flexion and loss of postural equilibrium, (B) asymmetrical tonic extension (arrow) with rigidity of the tail, (C) chewing mechanism (arrow), (D) beginning of the hypertonic phase, (E) hypertonic phase with characteristic rigid hind limb extension and (F) postictal immobility. The behavioural seizure lasted for 100 s.
Fig 3: Generation of the LGI1 knockout mouse. (A) Diagram showing LoxP and LoxP-Neo-LoxP sequences indicated by triangles (floxed allele). Exons 6 and 7 were removed by crossing the LGI1loxP mice with a PGK-Cre strain (knockout allele). (B–C) Western blots demonstrating the absence of native LGI1 protein in whole brain lysate of LGI1−/− mouse (at postnatal day 13) using the ab30868 antibody (B), and spinal cord lysate of LGI1−/− mouse using the sc-28238 antibody (C). Equal amounts of total protein were loaded as demonstrated by α-tubulin levels. (D) Western blot showing LGI1 expression during embryonic and postnatal development on C57BL/6 mouse brain lysate (ab30868) and α-tubulin used for internal control. (E) Western blot showing restricted expression of LGI1 in the brain and spinal cord of a postnatal day 15 wild-type mouse (ab30868). Equal amounts of total protein were loaded and Ponceau S staining was used as internal loading control.
Fig 4: Site-directed mutational analysis of the interaction between LGI1 and ADAM22 or ADAM23. Pull-down assay between LGI1 mutants and ADAM22 ECD or ADAM23 ECD. Indicated LGI1 mutants and ADAM22 ECD-FLAG or ADAM23 ECD-FLAG secreted from HEK293T cells were mixed and pulled-down with anti-FLAG antibody agarose. Shown are Western blots of the (co-)purified (upper two panels) and input (bottom) samples with indicated antibodies (a). Quantification of the amounts of the co-purified LGI1 with ADAM22 ECD-FLAG (orange) or with ADAM23 ECD-FLAG (light blue) is shown in the graph (b). Results are shown as mean ± s.e. (n = 4 independent experiments)
Fig 5: Missense ADLTE mutations in LGI1. a Schematic representation of 28 missense ADLTE mutations in LGI1 (red, secretion-defective; blue, secretion-competent; black, not examined). The drawing scheme of the domain organization of LGI1 is the same as that in Fig. 1a. b Mapping of 28 missense ADLTE mutations in LGI1 LRR and EPTP on the LGI1 structure. The amino-acid residues in the mutation sites are shown as spheres. The coloring scheme of the mutation sites is the same as that in a. c Pull-down assay between LGI1WT or LGI1R474Q and ADAM22 ECD-FLAG or ADAM23 ECD-FLAG. Shown are Western blots of the (co-)purified (pulled-down with FLAG antibody agarose) and input samples with indicated antibodies. d Kaplan–Meier survival plots of mice with secretion-competent ADLTE mutations. ***P < 0.001, log-rank test. Loss of LGI1 in Lgi1–/– mice and reexpression of LGI1 in Lgi1–/–;WT mice and Lgi1–/–;R474Q mice were confirmed by Western blots of brain lysates with indicated antibodies
Supplier Page from Abcam for Anti-Lgi1/EPT antibody